SARS: Modern Pandemic Episode

Over the years, pandemics have plagued humanity. Severe acute respiratory syndrome (SARS) or SARS is an example of a recent contemporary epidemic affecting the world. The SARS epidemic presents to the medical institutions and governments around the world how we face the problems of modern pandemics. In this article we will explore the origin of SARS and the steps to contain and treat pandemics. SARS appeared in the southern part of Guangdong province in mid-November 2002, but was not officially reported to Guangdong Provincial government medical institution until February 2003 (Ahmad, Krumkamp, ​​and Reintjes, 2009).

In 1918, half of the world's population is infected with 50 million people infected with Spain influenza. In 2003, humans again faced severe acute respiratory syndrome (SARS). SARS is a simple arousal phone to pay attention to Canada without preparing. In 2005, the World Health Organization (WHO) addressed this issue by implementing a list of influenza pandemic control plans. Canada answered this fear that the Ontario Influenza Pandemic Health Plan was not ready. One of the important ethical issues being addressed is the obligation that medical staff provide medical care when infectious diseases occur. In other words, medical staff from doctors to nurses and volunteers are obliged to go to work during the pandemic. During the pandemic crisis, we have to establish even more stringent guidelines for Canadian medical personnel treatment standards

In the past decade, the issue of trend change has entered a discussion on conversion. New infectious diseases like severe acute respiratory syndrome (SARS) and pandemic influenza reminded the emergency department that an emergency response plan is needed. This also applies to the classification of intensive care services. In this public health emergency, management focus shifts from "individual" to "statistics" from individual to population, trying to achieve maximum results from available resources. However, emergency personnel may not be able to keep up with each other's care and help them for the individual patient in need.

To prepare for the pandemic threat, cooperation between the government, industry and academia is necessary to overcome obstacles and ensure the fastest production of candidate vaccines. Recent SARS events show that international cooperation is truly possible even in the face of a truly global threat. Unfortunately, there are only a few institutions available for safety testing under the high level of biofouling required to treat highly pathogenic influenza viruses. Overcoming the technical barriers of effective vaccine production is only the beginning of a long and expensive process. The size of the manufacturing industry has its own problems, especially because factory workers are immune to the pathogen they will handle. The most important thing is the vaccine safety test, but we must have a balance between the necessity of safety testing and the need for rapid mass production of vaccines.